Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein 1% Ointment in Epidermolysis Bullosa Simplex
NCT03154333Phase 2Terminated
- Sponsor
- Castle Creek Biosciences
- Start
- Jun 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of AC-203 in epidermolysis bullosa simplex (EBS), sponsored by Castle Creek Biosciences. Started Jun 2017; status: terminated.
02
Drugs
AC-203
03
Conditions
epidermolysis bullosa simplex (EBS)
Beyond the preview
Go deeper on NCT03154333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03154333.